Aventus Thrombectomy System Pulmonary Embolism Clinical Study

NCT05907564 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2026-02-04

No results posted yet for this study

Summary

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Conditions

Interventions

DEVICE

Thrombectomy

Use of Aventus Thrombectomy System to treat pulmonary embolism

Sponsors & Collaborators

  • Inquis Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Jun Li, MD · University Hospitals

  • Saher Sabri, MD · MedStar Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-20
Primary Completion
2025-02-20
Completion
2026-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05907564 on ClinicalTrials.gov